BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26138841)

  • 41. Bisphosphonate therapy for osteogenesis imperfecta.
    Phillipi CA; Remmington T; Steiner RD
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005088. PubMed ID: 18843680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteogenesis imperfecta.
    Forlino A; Marini JC
    Lancet; 2016 Apr; 387(10028):1657-71. PubMed ID: 26542481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New trends in the treatment of osteogenesis imperfecta type III - own experience.
    Jakubowska-Pietkiewicz E; Chlebna-Sokół D
    Ortop Traumatol Rehabil; 2008; 10(6):593-601. PubMed ID: 19153548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.
    Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A
    Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.
    Zacharin M; Kanumakala S
    J Pediatr Endocrinol Metab; 2004 Nov; 17(11):1511-7. PubMed ID: 15570988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Idiopathic juvenile osteoporosis.
    Krassas GE
    Ann N Y Acad Sci; 2000; 900():409-12. PubMed ID: 10818429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in osteogenesis imperfecta.
    Cole WG
    Clin Orthop Relat Res; 2002 Aug; (401):6-16. PubMed ID: 12151877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisphosphonate use in children with pediatric osteoporosis and other bone conditions.
    Szalay EA
    J Pediatr Rehabil Med; 2014; 7(2):125-32. PubMed ID: 25096864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteogenesis imperfecta: lifelong management is imperative and feasible.
    Chevrel G; Meunier PJ
    Joint Bone Spine; 2001 Mar; 68(2):125-9. PubMed ID: 11324928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional significance of bone density measurements in children with osteogenesis imperfecta.
    Huang RP; Ambrose CG; Sullivan E; Haynes RJ
    J Bone Joint Surg Am; 2006 Jun; 88(6):1324-30. PubMed ID: 16757767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteogenesis imperfecta in children.
    Arshad F; Bishop N
    Bone; 2021 Jul; 148():115914. PubMed ID: 33722772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteogenesis imperfecta--clinical and molecular diversity.
    Roughley PJ; Rauch F; Glorieux FH
    Eur Cell Mater; 2003 Jun; 5():41-7; discussion 47. PubMed ID: 14562271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Oesteogenesis imperfecta--genetics, diagnosis and medical treatment].
    Brixen KT; Illum NO; Hansen B; Lund AM; Mosekilde L
    Ugeskr Laeger; 2007 Jan; 169(1):30-4. PubMed ID: 17217883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical review 1: Bisphosphonate use in childhood osteoporosis.
    Bachrach LK; Ward LM
    J Clin Endocrinol Metab; 2009 Feb; 94(2):400-9. PubMed ID: 19033370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type I osteogenesis imperfecta: diagnostic difficulties.
    Bischoff H; Freitag P; Jundt G; Steinmann B; Tyndall A; Theiler R
    Clin Rheumatol; 1999; 18(1):48-51. PubMed ID: 10088950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Premenopausal osteoporosis: how to treat?
    Martínez-Morillo M; Grados D; Holgado S
    Reumatol Clin; 2012; 8(2):93-7. PubMed ID: 22089064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent progress in diagnosis and treatment of osteogenesis imperfecta.
    Moriwake T; Seino Y
    Acta Paediatr Jpn; 1997 Aug; 39(4):521-7. PubMed ID: 9316304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclic bisphosphonate therapy in osteogenesis imperfecta type V.
    Fleming F; Woodhead HJ; Briody JN; Hall J; Cowell CT; Ault J; Kozlowski K; Sillence DO
    J Paediatr Child Health; 2005 Mar; 41(3):147-51. PubMed ID: 15790328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological and biological therapeutic strategies for osteogenesis imperfecta.
    Marom R; Lee YC; Grafe I; Lee B
    Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):367-383. PubMed ID: 27813341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.